Position in BIIB
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,287,501
+$406,968 QoQ
Shares Held
5,959
+24.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#417
of 1,036 holders
Holding Since
Jun 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BEESE FULMER INVESTMENT MANAGEMENT, INC. holds $63,634,330 across 9 Drug Manufacturers - General names. BIIB ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
136,876 | $34,762,397 | |
| 2 | ABBV |
AbbVie Inc.
|
35,935 | $9,042,683 | |
| 3 | LLY |
ELI LILLY & Co
|
7,338 | $8,801,418 | |
| 4 | MRK |
Merck & Co., Inc.
|
28,659 | $3,682,681 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
41,013 | $2,363,169 | |
| 6 | PFE |
Pfizer Inc
|
83,085 | $2,000,686 | |
| 7 | BIIB |
Biogen Inc.
This page
|
5,959 | $1,287,501 | |
| 8 | AMGN |
Amgen Inc
|
3,502 | $1,268,144 |
All Filings in BIIB
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,287,501 | 5,959 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $880,533 | 4,803 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $399,849 | 2,272 | Shares | Sole | 2026-02-05 | |
| 2020-06-30 | $5,351 | 20 | Shares | Sole | 2020-07-17 | |
| No filing history on record for this holder in this stock. | ||||||